Healthy Living/WellnessAstraZeneca Diabetes Drug Combo Faces Launch Delay As FDA Asks For More Clinical Trial Data Drug company AstraZeneca's launch for its new diabetes treatment has been postponed as FDA did not approve the company's application. FDA requires more clinical trial data for the new treatment.by Alyssa Navarro
Healthy Living/WellnessStaph Kills More Babies Than Superbugs: Low Birthweight Infants More At Risk Of Infectionby Katrina Pascual
Healthy Living/WellnessHow To Quit Smoking? Talking To Your Kids About The Dangers Can Help You Ditch The Habitby Angela Laguipo
Healthy Living/WellnessNovartis Cancer Drug Beneficial To Parkinson's Disease Patients, Reveals Early Stage Trialby Jim Algar
Healthy Living/WellnessSwedish Researchers Say New Drug For Alcohol Addiction One Step Closer To Realityby Angela Laguipo
Healthy Living/WellnessCalifornia Recalls Organic Pastures Dairy Raw Whole Milk Due To Bacterial Contaminationby Julienne Roman
Healthy Living/WellnessEarly Insulin Therapy Beneficial For Patients With Type 2 Diabetesby Katrina Pascual